Bio Green Med Solution, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.6M
- Price
- $0.849
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.78%
- Volume
- 3.6K
About
Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.
Quick stats
Shares outstanding6.6M
Computed float4.2M
Float / shares63.5%
Cash runway (months)48.1
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001130166
Websitehttps://www.bgmsglobal.com/
AI Summary
AI-generated1/21
minorneutrallegal litigation
Halper Sadeh LLC is Investigating Whether BZH, CBAN, ATKR, BGMS are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, announced it is investigating Atkore's $95.00-per-share cash sale to Prysmian S.p.A. for potential securities-law violations and breaches of fiduciary duty.
The same release also targets Beazer Homes' $33.50-per-share sale to Dream Finders Homes, Colony Bankcorp's merger with First Reliance Bancshares, and Bio Green Med Solution's merger with Future NRG, claiming insiders may receive benefits not available to ordinary shareholders.
This is a plaintiff-firm solicitation seeking shareholders to contact counsel on a contingency basis; it is not an issuer disclosure or court action and carries no new information about the deals.
Red flags
- law firm alleges insiders may stand to receive substantial financial benefits not available to ordinary shareholders
- deal terms may limit superior competing offers